You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Dengue Virus

Showing 1 - 25 of 6,569
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Dengue Trial in Syracuse (Dengue virus 1 Live Virus Human Challenge (DENV-1-LVHC), Dengue virus 3 Live Virus Human Challenge

Not yet recruiting
  • Dengue
  • Dengue virus 1 Live Virus Human Challenge (DENV-1-LVHC)
  • Dengue virus 3 Live Virus Human Challenge (DENV-3-LVHC)
  • Syracuse, New York
    State University of New York, Upstate Medical University (SUNY-U
Jul 28, 2023

Healthy Volunteers Trial in Philadelphia (INO-A002, CELLECTRA® 2000, Dengue Fever Antibodies (IgG))

Completed
  • Healthy Volunteers
  • INO-A002
  • +2 more
  • Philadelphia, Pennsylvania
    University of Pennsylvania
Nov 7, 2022

Dengue Trial in Lausanne (LD vehicle-GNP, LD PepGNP-Dengue, HD vehicle-GNP)

Completed
  • Dengue
  • LD vehicle-GNP
  • +3 more
  • Lausanne, Vaud, Switzerland
    Center for Primary Care and Public Health, (Unisante)
Nov 28, 2022

Dengue Trial in Syracuse (Dengue virus 3 Live Virus Human Challenge (DENV-3-LVHC))

Completed
  • Dengue
  • Dengue virus 3 Live Virus Human Challenge (DENV-3-LVHC)
  • Syracuse, New York
    State University of New York, Upstate Medical University (SUNY-U
Jun 10, 2022

Evaluation Study of Dengue RDTs

Recruiting
  • Dengue Fever
  • Diagnostic test: 5 different Rapid diagnostic test and Reference tests
  • Karachi, Sindh, Pakistan
    Aga Khan University
Oct 12, 2022

Dengue Virus Infection Trial in Curitiba (CYD-TDV Dengue Vaccine)

Recruiting
  • Dengue Virus Infection
  • CYD-TDV Dengue Vaccine
  • Curitiba, Brazil
    BRAZIL
Jan 3, 2023

Dengue Disease, Dengue Virus Trial (V181 High-Potency Level, V181 Mid-Potency Level, V181 Low-Potency Level)

Not yet recruiting
  • Dengue Disease
  • Dengue Virus
  • V181 High-Potency Level
  • +3 more
  • (no location specified)
Aug 17, 2022

Dengue Virus, Dengue Fever, Dengue Hemorrhagic Fever Trial in Bangkok (CYD Dengue Vaccine, Inactivated rabies virus vaccine,

Completed
Has Results
  • Dengue Virus
  • +3 more
  • CYD Dengue Vaccine
  • +2 more
  • Bangkok, Thailand
    Sanofi Pasteur Investigational Site
Mar 10, 2022

Dengue Trial in Baltimore (Dengue 1 Live Virus Human Challenge (DENV-1-LVHC))

Completed
  • Dengue
  • Dengue 1 Live Virus Human Challenge (DENV-1-LVHC)
  • Baltimore, Maryland
    University of Maryland, Baltimore, Center for Vaccine Developmen
Oct 27, 2021

Healthy, Zika Trial in San Juan (GLS-5700, Placebo)

Completed
  • Healthy
  • Zika
  • GLS-5700
  • Placebo
  • San Juan, Puerto Rico
  • +2 more
Jan 5, 2022

Dengue Fever, Dengue Hemorrhagic Fever, Dengue Virus Trial in Singapore (CYD Dengue vaccine, NaCl + influenza virus or hepatitis

Completed
Has Results
  • Dengue Fever
  • +3 more
  • CYD Dengue vaccine
  • NaCl + influenza virus or hepatitis A vaccine
  • Singapore, Singapore
  • +4 more
Mar 10, 2022

Dengue Virus, Dengue Fever, Dengue Hemorrhagic Fever Trial in Chulucanas Morropon (CYD Dengue Vaccine Serotypes 1, 2, 3, and 4,

Completed
Has Results
  • Dengue Virus
  • +3 more
  • CYD Dengue Vaccine Serotypes 1, 2, 3, and 4
  • Pneumococcal polysaccharide vaccine
  • Chulucanas Morropon, Piura, Peru
    (unnamed)
Mar 10, 2022

Dengue Virus, Dengue Fever, Dengue Hemorrhagic Fever Trial in Long Xuyên (CYD dengue vaccine serotypes (1, 2, 3, 4).,

Completed
Has Results
  • Dengue Virus
  • +3 more
  • CYD dengue vaccine serotypes (1, 2, 3, 4).
  • Meningococcal Polysaccharide A+C; NaCl; Typhoid Vi polysaccharide
  • Long Xuyên, An Giang Province, Vietnam
    Sanofi Pasteur Investigational Site
Mar 15, 2022

Dengue, Dengue Hemorrhagic Fever, Dengue Virus Trial in Worldwide (CYD Dengue Vaccine, Tetanus Toxoid Reduced Diphtheria Toxoid

Completed
Has Results
  • Dengue
  • +3 more
  • CYD Dengue Vaccine
  • Tetanus Toxoid Reduced Diphtheria Toxoid Acellular Pertussis
  • Bucaramanga, Colombia
  • +3 more
Mar 15, 2022

Dengue Trial in Baltimore (Dengue 4 Live Virus Human Challenge (DENV-4-LVHC) - Low Dose, Dengue 4 Live Virus Human Challenge

Recruiting
  • Dengue
  • Dengue 4 Live Virus Human Challenge (DENV-4-LVHC) - Low Dose
  • +2 more
  • Baltimore, Maryland
    University of Maryland, Baltimore, Center for Vaccine Developmen
Mar 1, 2022

Dengue Trial in Mexico city (Estimate the distribution of antibodies by serotype by Dengue virus in areas of low and high

Not yet recruiting
  • Dengue
  • Estimate the distribution of antibodies by serotype by Dengue virus in areas of low and high incidence of dengue
  • Mexico city, Mexico
    Mexican Society of Public Health
Mar 2, 2022

Dengue, Dengue Fever, Dengue Hemorrhagic Fever Trial in United States (Live, attenuated, recombinant dengue serotypes 1, 2, 3,

Completed
Has Results
  • Dengue
  • +3 more
  • Live, attenuated, recombinant dengue serotypes 1, 2, 3, and 4 virus
  • Yellow Fever
  • Alabaster, Alabama
  • +6 more
Mar 15, 2022

Prevention of Dengue Fever Trial in Adelaide (Dengusiil, Placebo)

Completed
  • Prevention of Dengue Fever
  • Dengusiil
  • Placebo
  • Adelaide, South Australia, Australia
    CMAX Clinical Research Pty Ltd
Aug 16, 2022

Dengue, Dengue Hemorrhagic Fever Trial in Mexico (Live, attenuated, recombinant dengue serotype 1, 2, 3, and 4 virus, DTaP

Completed
Has Results
  • Dengue
  • Dengue Hemorrhagic Fever
  • Live, attenuated, recombinant dengue serotype 1, 2, 3, and 4 virus
  • +4 more
  • Acapulco, Guerrero, Mexico
  • +3 more
Mar 15, 2022

Dengue, Dengue Fever, Dengue Hemorrhagic Fever Trial in India (Live, attenuated, recombinant dengue serotype 1, 2, 3, 4 virus,

Completed
Has Results
  • Dengue
  • +2 more
  • Live, attenuated, recombinant dengue serotype 1, 2, 3, 4 virus
  • Placebo: NaCl 0.9% solution
  • Bangalore, Karnataka, India
  • +4 more
Mar 15, 2022

Dengue Virus Trial in Silver Spring (TDENV-PIV, TDENV-LAV F17)

Active, not recruiting
  • Dengue Virus
  • TDENV-PIV
  • TDENV-LAV F17
  • Silver Spring, Maryland
    WRAIR, Clinical Trials Center
Mar 25, 2021

Dengue Fever, Dengue Hemorrhagic Fever Trial in Malaysia (Live, attenuated, recombinant dengue serotypes 1, 2, 3, and 4 virus,

Completed
Has Results
  • Dengue Fever
  • Dengue Hemorrhagic Fever
  • Live, attenuated, recombinant dengue serotypes 1, 2, 3, and 4 virus
  • Placebo: NaCl 0.9%
  • Ipoh, Perak, Malaysia
  • +3 more
Mar 15, 2022

Dengue, Dengue Hemorrhagic Fever, Yellow Fever Trial in Cali, Lima (Live, attenuated dengue serotype 1, 2, 3, and 4 virus,

Completed
Has Results
  • Dengue
  • +2 more
  • Live, attenuated dengue serotype 1, 2, 3, and 4 virus
  • +8 more
  • Cali, Colombia
  • +1 more
Mar 15, 2022

Dengue, Dengue Hemorrhagic Fever Trial in Vitória (Live, attenuated, recombinant dengue serotype 1 , 2, 3 , and 4 virus, NaCl

Completed
Has Results
  • Dengue
  • Dengue Hemorrhagic Fever
  • Live, attenuated, recombinant dengue serotype 1 , 2, 3 , and 4 virus
  • +3 more
  • Vitória, Brazil
    (unnamed)
Mar 10, 2022

Healthy Volunteers Trial in United Kingdom (TDV, HAV Vaccine, TDV Placebo)

Completed
Has Results
  • Healthy Volunteers
  • TDV
  • +3 more
  • Edgbaston, Birmingham, United Kingdom
  • +9 more
Aug 17, 2022